NARA Discovery
Article Details
← Back to Search Results
Journal Article

Mechanistic aspects of ameliorative effects of Eicosapentanoic acid ethyl ester on methotrexate-evoked testiculopathy in rats

Noha A. T. Abbas; Shaimaa S. El-Sayed; Samaa Salah Abd El-Fatah; Walaa M. Sarhan; Eman M. A. Abdelghany; Omnia Sarhan; Shireen S. Mahmoud
Naunyn-Schmiedeberg's Archives of Pharmacology · Vol. 397, Issue 1 · pp. 357-369 · 2024

Abstract

Disrupted spermatogenesis and testicular injury are among the devastating outcomes of methotrexate. A major contributor to methotrexate-induced testiculopathy is oxidative damage which triggers apoptosis and altered autophagy responses. Eicosapentaenoic acid ethyl ester (EPA-E) is an antihyperlipidemic derivative of omega-3 fatty acids that exhibited affinity to peroxisome proliferator-activated receptor-γ (PPAR-γ) that possesses both antioxidant and autophagy modulating properties. This is an exploratory study aiming at assessing the effectiveness of EPA-E to alleviate testicular damage induced by methotrexate. The specific exploratory hypothesis of this experiment is: EPA-E administration for 1 week to methotrexate-treated rats reduces testicular damage compared to control rats. As a secondary outcome, we were interested in identifying the implicated mechanism that mediates the action of EPA-E. In adult male Wistar rats, testiculopathy was achieved by a single methotrexate injection (20 mg/kg, ip ). Rats received vehicle, EPA-E (0.3 g/kg/day, po ) alone or with selective PPAR-γ antagonist (bisphenol A diglycidyl ether, BADGE) at 30 mg/kg/day, ip for 1 week. EPA-E recuperated methotrexate-attenuated serum total testosterone while reduced testicular inflammation and oxidative stress, restoring superoxide dismutase (SOD) while reducing malondialdehyde (MDA) and 8–hydroxy–2′-deoxyguanosine (8-OHdG). Methotrexate-induced testicular apoptosis (caspase-3 and p53) was suppressed upon EPA-E treatment. Besides, EPA-E curbed methotrexate-induced abnormal autophagy by downregulating LC3A/B and beclin-1. Interestingly, BADGE-coadministration reversed EPA-E beneficial actions. Collectively, our findings suggest PPAR-γ role in EPA-E-mediated mitigation of methotrexate-evoked testiculopathy via suppression of oxidative stress, apoptosis, as well as abnormal autophagy. Furthermore, EPA-E could be used as a preventive therapy for some testiculopathies mediated by oxidative stress. Graphical Abstract

Bibliographic Information

JournalNaunyn-Schmiedeberg's Archives of Pharmacology
PublisherSpringer
Publication Date2024-01-01
Publication Year2024
Volume397
Issue1
Pages357-369
Document TypeJournal Article
Print ISSN0028-1298
eISSN1432-1912
DOI10.1007/s00210-023-02577-4

Access Information

NARA Access Coverage1873-01-01~Current
Journal Homepagehttps://www.springer.com/journal/210
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.